Original Research
Page 12
Original Research
Impact of SUD on COVID-19 Outcomes
August 29, 2022
Identifying risk factors that predispose individuals to negative COVID-19 outcomes is important. The current study examined the association between substance use disorders, psychiatric diagnosis, and COVID-19–related clinical outcomes.
Original Research
Add-on Pramipexole for Schizophrenia
August 1, 2022
Several small clinical trials have reported that the dopamine agonist pramipexole was beneficial in treating patients with schizophrenia. This 16-week, multicenter, double-blind, randomized, placebo-controlled study was conducted to test...
Original Research
Amphetamine Extended-Release Tablets for Adult ADHD
July 20, 2022
Treating attention-deficit/hyperactivity disorder (ADHD) in adults can improve long-term outcomes, such as reducing suicidal behavior and mortality. This study evaluated the efficacy and safety of amphetamine extended-release tablets in...
Original Research
Vaccination Among Children With Developmental Delay and Their Siblings
July 12, 2022
Given concerns, despite evidence to the contrary, regarding the association between vaccination and autism, this study assessed vaccination uptake and its associated factors in siblings of children with developmental...
Original Research
Sexual Health, Substance Use, and ADHD in College Students
June 29, 2022
College students with attention-deficit/hyperactivity disorder (ADHD) may have increased risk for poor sexual health. This study examined the sexual health of college students with and without ADHD and identified...